
  
    
      
        Introduction_NNP
        Iron_NNP is_VBZ one_CD of_IN the_DT essential_JJ nutrients_NNS required_VBN by_IN the_DT
        bacteria_NNS to_TO be_VB able_JJ to_TO multiply_VB and_CC invade_VB a_DT vertebrate_NN
        host_NN ._. However_RB as_IN a_DT defense_NN mechanism_NN ,_, availability_NN of_IN iron_NN
        for_IN the_DT bacteria_NNS is_VBZ limited_VBN in_IN the_DT host_NN as_IN most_JJS of_IN it_PRP
        complexed_JJ to_TO ferritin_NN ,_, transferrin_NN ,_, hemoglobin_NN ,_, heme_NN and_CC
        hemosiderin_NN [_NN 1_CD 2_CD 3_CD 4_CD ]_NN ._. For_IN pathogenic_JJ bacteria_NNS to_TO be_VB
        able_JJ to_TO establish_VB an_DT infection_NN ,_, it_PRP must_MD compete_VB with_IN and_CC
        obtain_VB iron_NN from_IN the_DT host_NN 's_POS iron_NN binding_JJ protein_NN [_NN 5_CD ]_NN ._.
        The_DT bacteria_NNS have_VBP evolved_VBN a_DT number_NN of_IN diverse_JJ mechanisms_NNS
        utilize_VB the_DT host_NN iron_NN ._. One_CD of_IN the_DT methods_NNS of_IN achieving_VBG
        this_DT ,_, is_VBZ by_IN secretion_NN of_IN low_JJ molecular_JJ weight_NN high_JJ affinity_NN
        iron_NN chelators_NNS termed_VBD siderophores_NNS and_CC their_PRP$ specific_JJ cell_NN
        surface_NN receptor_NN ,_, Iron_NNP Regulated_NNP Outer_NNP Membrane_NNP Proteins_NNPS
        (_( IROMPs_NNP )_) ._. These_DT receptors_NNS are_VBP expressed_VBN under_IN iron_NN
        restricted_VBD conditions_NNS [_NN 6_CD 7_CD 8_CD 9_CD ]_NN ._. The_DT role_NN of_IN IROMPs_NNP in_IN
        iron_NN uptake_NN have_VBP been_VBN reported_VBN for_IN other_JJ bacteria_NNS like_IN 
        Escherichia_NNP coli_NNS ,_, 
        Pseudomonas_NNP aeruginosa_NN and_CC 
        Neisseria_NNP gonorrheae_NN ._. Antibodies_NNP
        directed_VBD against_IN these_DT proteins_NNS associated_VBN with_IN iron_NN uptake_NN
        exert_VB a_DT bacteriostatic_JJ or_CC bactericidal_NN effect_NN ,_, by_IN blocking_VBG
        siderophore_NN mediated_JJ iron_NN uptake_NN pathways_NNS [_NN 10_CD 11_CD 12_CD 13_CD 14_CD
        ]_NN ._.
        
        A_DT ._. baumannii_NN is_VBZ widely_RB recognized_VBN as_IN
        an_DT emerging_VBG nosocomial_NN pathogen_NN and_CC is_VBZ of_IN particular_JJ
        concern_NN due_JJ to_TO the_DT spread_NN of_IN multi-drug_JJ resistant_JJ strain_NN [_NN
        15_CD 16_CD ]_NN ._. 
        A_DT ._. baumannii_NN has_VBZ also_RB been_VBN shown_VBN to_TO
        produce_VB siderophores_NNS and_CC expresses_VBZ IROMPs_NNP under_IN iron_NN
        restricted_VBD conditions_NNS [_NN 17_CD 18_CD ]_NN ._. Smith_NNP and_CC Alpar_NNP had_VBD shown_VBN
        the_DT specific_JJ antibody_NN response_NN to_TO IROMPs_NNP in_IN patients_NNS
        suffering_VBG from_IN 
        A_DT ._. calcoaceticus_JJ septicemia_NN in_IN the_DT
        convalescent_NN sera_NN [_NN 19_CD ]_NN ._.
        We_PRP carried_VBD out_RP the_DT present_JJ study_NN to_TO characterize_VB the_DT
        IROMPs_NNP 
        A_DT ._. baumannii_NN ATCC_NNP 19606_CD by_IN producing_VBG
        monoclonal_NN antibodies_NNS against_IN them_PRP ._. Western_JJ blot_NN analysis_NN
        was_VBD performed_VBN to_TO study_VB their_PRP$ specificity_NN ._. These_DT monoclonal_NN
        antibodies_NNS were_VBD tested_VBN for_IN their_PRP$ 
        in-vitro_JJ bactericidal_NN activity_NN and_CC
        opsonizing_VBG activity_NN ._. Apart_RB from_IN this_DT their_PRP$ role_NN in_IN blocking_VBG
        the_DT siderophore_NN mediated_JJ iron_NN uptake_NN system_NN was_VBD also_RB
        studied_VBN ._.
      
      
        Results_NNS
        
          Expression_NNP of_IN IROMPs_NNP and_CC effect_NN of_IN Iron_NNP on_IN
          growth_NN
          OMP_NNP profiles_NNS of_IN 
          A_DT ._. baumannii_NN grown_VBN in_IN CDM-Fe_NNP and_CC
          CDM_NNP +_NN Fe_NNP were_VBD compared_VBN on_IN SDS-PAGE_NNP and_CC it_PRP was_VBD seen_VBN that_IN in_IN
          absence_NN of_IN iron_NN ,_, bacteria_NNS developed_VBD 4_CD new_JJ outer_JJ membrane_NN
          proteins_NNS which_WDT were_VBD absent_JJ in_IN iron_NN replete_JJ conditions_NNS ._.
          These_DT new_JJ proteins_NNS are_VBP in_IN the_DT range_NN of_IN 77_CD kDa_NN to_TO 88_CD kDa_NN
          and_CC were_VBD the_DT IROMPs_NNP (_( Fig_NNP ._. 1_LS )_) ._.
        
        
          Monoclonal_NNP antibody_NN production_NN
          Five_CD best_JJS reactive_JJ monoclonal_NN antibodies_NNS were_VBD selected_VBN
          out_IN of_IN 88_CD clones_NNS after_IN 2_CD fusions_NNS based_VBN upon_IN their_PRP$
          reactivity_NN to_TO IROMPs_NNP by_IN ELISA_NNP ._. These_DT monoclonal_NN
          antibodies_NNS were_VBD named_VBN as_IN 3_CD D_NNP 
          5_CD ABIR_NNP ,_, 1_CD D_NNP 
          11_CD ABIR_NNP ,_, 2_CD G_NNP 
          9_CD ABIR_NNP ,_, 1_CD F_NN 
          7_CD ABIR_NNP ,_, and_CC 5_CD D_NNP 
          6_CD ABIR_NNP ._. All_DT of_IN the_DT five_CD monoclonal_NN
          antibodies_NNS were_VBD of_IN IgM_NNP isotypes_NNS (_( Table_NNP 1_LS )_) ._. These_DT
          monoclonal_NN antibodies_NNS were_VBD tested_VBN in_IN Western_JJ blots_NNS ._. Fig_NNP ._.
          2_LS shows_VBZ the_DT results_NNS of_IN western_JJ immunoblots_NNS of_IN OMPs_NNP ._. All_DT
          the_DT monoclonal_NN antibodies_NNS reacted_VBD with_IN one_CD or_CC more_JJR OMP_NNP
          bands_NNS corresponding_JJ to_TO the_DT range_NN of_IN IROMPs_NNP but_CC none_NN
          reacted_VBD with_IN the_DT OMPs_NNP of_IN bacteria_NNS grown_VBN in_IN CDM_NNP +_NN Fe_NNP media_NNS ._.
          Two_CD antibodies_NNS (_( 5_CD D_NNP 
          6_CD ABIR_NNP and_CC 1_CD F_NN 
          7_CD ABIR_NNP )_) did_VBD not_RB show_VB any_DT reactivity_NN on_IN
          Western_JJ blot_NN this_DT may_MD be_VB due_JJ to_TO conformational_NN changes_NNS of_IN
          epitope_NN of_IN proteins_NNS ._. All_DT of_IN the_DT antibodies_NNS were_VBD tested_VBN
          against_IN 
          E_NNP ._. coli_NNS and_CC 
          Pseudomonas_NNP aerugionsa_NN and_CC none_NN of_IN
          them_PRP were_VBD cross_NN reactive_JJ with_IN IROMPs_NNP of_IN these_DT two_CD
          bacteria_NNS on_IN ELISA_NNP ._.
        
        
          Characterization_NNP of_IN monoclonal_NN antibodies_NNS
          
            Bactericidal_NNP activity_NN
            All_DT these_DT monoclonal_NN antibodies_NNS were_VBD tested_VBN for_IN
            their_PRP$ bactericidal_NN activity_NN against_IN 
            A_DT ._. baumannii_NN ATCC_NNP 19606_CD in-vitro_JJ ._.
            It_PRP was_VBD found_VBN that_IN all_PDT the_DT five_CD monoclonal_NN antibodies_NNS
            are_VBP bactericidal_NN and_CC they_PRP specifically_RB kill_VBP the_DT
            bacteria_NNS grown_VBN in_IN CDM-Fe_NNP media_NNS ._. The_DT %_NN of_IN reduction_NN or_CC
            killing_VBG was_VBD 80_CD -_: 90_CD %_NN ,_, and_CC various_JJ controls_NNS gave_VBD 10_CD -_: 20_CD %_NN
            reduction_NN in_IN bacterial_JJ colony_NN (_( Table_NNP 2_LS )_) ._.
          
          
            Opsonising_NNP activity_NN
            It_PRP was_VBD found_VBN that_IN human_JJ PMNs_NNP opsonize_NN bacteria_NNS more_RBR
            readily_RB when_WRB bacteria_NNS is_VBZ preincubated_JJ with_IN monoclonal_NN
            antibodies_NNS as_IN is_VBZ evident_JJ by_IN counting_VBG the_DT bacteria_NNS
            within_IN the_DT PMNs_NNP (_( Table_NNP 2_LS )_) as_IN compared_VBN to_TO controls_NNS ._. The_DT
            opsonization_NN activity_NN of_IN PMNs_NNP was_VBD increased_VBD 6_CD -_: 8_CD folds_NNS
            by_IN prior_JJ incubation_NN with_IN monoclonal_NN antibodies_NNS ._.
          
          
            Uptake_NNP of_IN Iron_NNP through_IN siderophore_NN
            The_DT siderophore_NN was_VBD secreted_JJ by_IN 
            Acinetobacter_NNP buamnnii_NN ATCC_NNP 19606_CD
            was_VBD catechole_NN type_NN as_IN determined_VBN by_IN Arnow_NNP 's_POS method_NN ._. The_DT
            uptake_NN of_IN radiolabeled_JJ iron_NN siderophore_NN complex_JJ by_IN the_DT
            bacterial_JJ whole_JJ cells_NNS in_IN CDM-Fe_NNP was_VBD significantly_RB more_JJR
            than_IN that_DT in_IN case_NN of_IN bacterial_JJ cells_NNS obtained_VBN from_IN
            CDM_NNP +_NN Fe_NNP medium_NN (_( Fig_NNP ._. 3_LS )_) ._. The_DT control_NN tubes_NNS incubated_JJ
            only_RB with_IN 55_CD Fe_NNP without_IN siderophore_NN showed_VBD negligible_JJ
            iron_NN uptake_NN ._. Total_JJ radioactivity_NN bound_VBN to_TO the_DT filter_NN in_IN
            case_NN of_IN iron_NN deficient_NN bacteria_NNS with_IN radioactive_JJ
            siderophore_NN complex_NN was_VBD about_IN 85_CD %_NN out_IN of_IN the_DT 100_CD %_NN
            radioactivity_NN taken_VBN of_IN the_DT neat_JJ 55_CD Fe_NNP ._. In_IN control_NN as_RB
            well_RB as_IN with_IN iron_NN rich_JJ bacteria_NNS it_PRP was_VBD not_RB more_JJR than_IN
            15_CD -_: 25_CD %_NN ._. This_DT suggests_VBZ that_IN the_DT iron_NN uptake_NN is_VBZ mediated_JJ
            through_IN siderophore_NN ._. The_DT data_NNS was_VBD analyzed_VBN by_IN
            nonparametric_JJ Willcoxan_NNP Rank_NNP Sum_NNP Test_NNP for_IN two_CD groups_NNS ._.
            It_PRP was_VBD found_VBN that_DT iron_NN uptake_NN by_IN iron_NN deficient_NN cells_NNS
            was_VBD significantly_RB more_JJR as_IN compared_VBN to_TO iron_VB rich_JJ cells_NNS
            (_( p_NN value_NN <_NN 0_CD ._. 05_CD )_) ._. Similarly_RB there_EX was_VBD a_DT significant_JJ
            difference_NN in_IN CPM_NNP reading_NN of_IN iron_NN deficient_NN cells_NNS for_IN
            uptake_NN through_IN siderophore_NN (_( p_NN value_NN <_NN 0_CD ._. 05_CD )_) as_IN
            compared_VBN to_TO the_DT control_NN cells_NNS in_IN which_WDT no_DT siderophore_NN
            was_VBD added_VBN ._.
          
          
            Binding_NNP of_IN 59_CD Fe-_NNP Siderophore_NNP complex_JJ to_TO OMP_NNP
            The_DT outer_JJ membrane_NN proteins_NNS prepared_VBN from_IN cells_NNS
            grown_VBN in_IN the_DT absence_NN of_IN iron_NN bound_VBN significantly_RB higher_JJR
            amount_NN of_IN radioactive_JJ iron_NN siderophore_NN complex_JJ as_IN
            compared_VBN to_TO that_DT of_IN the_DT OMP_NNP prepared_VBD from_IN cells_NNS grown_VBN
            in_IN iron_NN rich_JJ conditions_NNS (_( p_NN value_NN <_NN 0_CD ._. 05_CD )_) ._. Similarly_RB
            there_EX was_VBD no_DT binding_JJ of_IN radiolabeled_JJ 59_CD Fe_NNP alone_RB to_TO the_DT
            filters_NNS in_IN absence_NN of_IN siderophore_NN which_WDT was_VBD put_VBN up_RB as_IN
            control_NN ._. This_DT strongly_RB indicates_VBZ that_IN OMP_NNP of_IN CDM-Fe_NNP
            grown_VBN bacteria_NNS contains_VBZ the_DT IROMPs_NNP and_CC that_IN they_PRP bind_NN
            to_TO the_DT iron_NN siderophore_NN complex_JJ ,_, hence_RB they_PRP may_MD be_VB the_DT
            receptor_NN for_IN siderophore_NN iron_NN complex_JJ ._. (_( Fig_NNP ._. 4_LS )_) ._. That_DT
            binding_JJ receptor_NN ,_, a_DT protein_NN was_VBD proved_VBN by_IN preincubating_VBG
            the_DT OMPs_NNP with_IN proteinase_NN K_NNP that_WDT abolished_VBD all_PDT the_DT
            binding_JJ activity_NN of_IN the_DT iron_NN siderophore_NN complex_JJ (_( Fig_NNP ._.
            4_LS )_) ._.
          
          
            Role_NNP of_IN monoclonal_NN antibody_NN in_IN Iron_NNP
            pathway_NN
            The_DT iron_NN uptake_NN by_IN 
            A_DT ._. baumannii_NN ATCC_NNP 19606_CD when_WRB
            grown_VBN in_IN CDM-Fe_NNP was_VBD inhibited_VBD more_JJR than_IN 90_CD %_NN by_IN
            monoclonal_NN antibodies_NNS directed_VBN against_IN IROMPs_NNP of_IN 
            A_DT ._. bauamannii_NN ,_, as_IN compared_VBN to_TO
            bacteria_NNS grown_VBN in_IN CDM_NNP +_NN Fe_NNP (_( Fig_NNP ._. 5_LS ,_, p_NN value_NN <_NN 0_CD ._. 05_CD )_) ._.
            Similarly_RB ,_, monoclonal_NN antibodies_NNS resulted_VBD in_IN almost_RB
            complete_JJ inhibition_NN of_IN binding_JJ of_IN 55_CD Fe_NNP siderophore_NN
            complex_JJ to_TO its_PRP$ receptor_NN IROMPs_NNP ,_, which_WDT are_VBP the_DT component_NN
            of_IN OMPs_NNP (_( p_NN value_NN <_NN 0_CD ._. 05_CD )_) ._. But_CC there_EX was_VBD no_DT effect_NN on_IN
            binding_JJ and_CC uptake_NN of_IN iron_NN siderophore_NN complex_JJ in_IN
            absence_NN of_IN monoclonal_NN antibodies_NNS or_CC with_IN control_NN sera_NN
            (_( Fig_NNP ._. 5_LS )_) ._.
          
        
      
      
        Discussion_NNP
        Iron_NNP is_VBZ an_DT important_JJ nutritional_JJ requirement_NN of_IN living_VBG
        cells_NNS ._. Iron_NNP is_VBZ not_RB readily_RB available_JJ to_TO the_DT microbes_NNS ,_, which_WDT
        invades_VBZ the_DT human_JJ hosts_NNS [_NN 20_CD ]_NN as_IN a_DT part_NN of_IN host_NN defense_NN
        mechanism_NN against_IN bacterial_JJ infections_NNS ._. In_IN iron_NN starved_VBN
        conditions_NNS ,_, bacterial_JJ growth_NN rate_NN is_VBZ reduced_VBN and_CC
        morphological_JJ changes_NNS such_JJ as_IN filament_NN formation_NN takes_VBZ
        place_NN which_WDT suggests_VBZ an_DT inhibition_NN of_IN DNA_NNP synthesis_NN or_CC cell_NN
        division_NN [_NN 21_CD 22_CD ]_NN ._. Besides_IN these_DT the_DT concentration_NN of_IN the_DT
        proteins_NNS whose_WP$ synthesis_NN is_VBZ regulated_VBN by_IN iron_NN are_VBP also_RB
        observed_VBN to_TO get_VB changed_VBN [_NN 23_CD ]_NN ._.
        To_TO acquire_VB the_DT iron_NN essential_JJ for_IN their_PRP$ growth_NN and_CC
        metabolism_NN ,_, the_DT microbes_NNS have_VBP evolved_VBN the_DT ability_NN to_TO
        compete_VB with_IN host_NN iron_NN binding_JJ factors_NNS ._. This_DT is_VBZ achieved_VBN by_IN
        producing_VBG powerful_JJ iron_NN chelators_NNS known_VBN as_IN siderophores_NNS [_NN
        24_CD 25_CD 26_CD 27_CD ]_NN ._. Siderophores_NNP are_VBP secreted_JJ in_IN the_DT external_JJ
        melieu_NN where_WRB they_PRP compete_VBP with_IN host_NN iron_NN binding_JJ proteins_NNS
        to_TO capture_VB iron_NN by_IN forming_VBG iron-siderophore_JJ complex_NN ._. This_DT
        gets_VBZ internalized_JJ through_IN the_DT specific_JJ outer_JJ membrane_NN
        protein_NN receptors_NNS ,_, termed_VBD as_IN Iron_NNP Regulated_NNP Outer_NNP Membrane_NNP
        Proteins_NNPS (_( IROMPs_NNP )_) ._.
        We_PRP found_VBD that_IN when_WRB 
        A_DT ._. baumannii_NN was_VBD grown_VBN in_IN iron_NN
        deficient_NN medium_NN ,_, IROMPs_NNP were_VBD expressed_VBN on_IN their_PRP$ outer_JJ
        membranes_NNS with_IN molecular_JJ weight_NN of_IN 88_CD ,_, 84_CD ,_, 80_CD and_CC 77_CD kDa_NN ._.
        We_PRP also_RB found_VBD that_IN 
        A_DT ._. baumannii_NN secreted_JJ catehcol_NN type_NN
        of_IN siderophore_NN in_IN the_DT external_JJ melieu_NN ._. Daniel_NNP et_CC ._. al_NN ._. [_NN 28_CD ]_NN
        also_RB reported_VBD the_DT production_NN of_IN IROMPs_NNP and_CC siderophore_NN
        during_IN different_JJ phase_NN of_IN growth_NN cycle_NN in_IN iron_NN starved_VBN
        medium_NN by_IN 
        A_DT ._. baumannii_NN ._. The_DT molecular_JJ weight_NN
        of_IN these_DT proteins_NNS described_VBN by_IN them_PRP were_VBD in_IN between_IN 70_CD -_: 80_CD
        kDa_NN of_IN these_DT 75_CD and_CC 80_CD kDa_NN are_VBP expressed_VBN more_RBR strongly_RB in_IN
        iron_NN repressed_JJ bacteria_NNS ._. They_PRP have_VBP also_RB cloned_VBN and_CC
        characterized_VBD the_DT 
        fur_NN regulator_NN gene_NN of_IN the_DT IROMPs_NNP ._.
        Apart_RB from_IN these_DT ,_, some_DT other_JJ high_JJ molecular_JJ weight_NN
        IROMPs_NNP in_IN 
        Acinetobacter_NNP have_VBP also_RB been_VBN
        identified_VBN by_IN Echenique_NNP et_CC al_NN ._. on_IN SDS-PAGE_NNP [_NN 29_CD ]_NN ._. Smith_NNP
        and_CC Alpar_NNP also_RB demonstrated_VBD the_DT reactivity_NN by_IN
        immunoblotting_VBG against_IN the_DT IROMPs_NNP using_VBG the_DT sera_NN of_IN
        convalescent_NN patients_NNS recovering_VBG from_IN 
        Acinetobacter_NNP infection_NN sera_NN by_IN Smith_NNP
        and_CC Alpar_NNP [_NN 18_CD ]_NN ._.
        In_IN order_NN to_TO further_VB characterize_VB the_DT biological_JJ
        properties_NNS of_IN IROMPs_NNP and_CC role_NN of_IN the_DT antibodies_NNS produced_VBN
        against_IN them_PRP ,_, we_PRP raised_VBD monoclonal_NN antibodies_NNS to_TO the_DT IROMPs_NNP
        by_IN hybridoma_NN technology_NN ._. The_DT five_CD best_JJS reactive_JJ and_CC
        specific_JJ clones_NNS ,_, which_WDT were_VBD selected_VBN after_IN subcloning_VBG ,_,
        belonged_VBD to_TO IgM_NNP class_NN ._. On_IN western_JJ blot_NN however_RB only_RB 3_CD
        clones_NNS reacted_VBD with_IN the_DT bands_NNS corresponding_JJ to_TO IROMPs_NNP ._. The_DT
        reason_NN for_IN none_NN of_IN the_DT clones_NNS reacting_VBG ,_, could_MD be_VB due_JJ to_TO the_DT
        fact_NN that_IN monoclonal_NN antibodies_NNS recognize_VBP only_RB an_DT epitope_NN
        whose_WP$ tertiary_JJ structure_NN might_MD be_VB changed_VBN during_IN
        denaturation_NN conditions_NNS of_IN SDS-PAGE_NNP ._.
        The_DT anti_NN IROMPs_NNP antibodies_NNS showed_VBD significant_JJ 
        in-vitro_JJ bactericidal_NN activity_NN
        against_IN 
        A_DT ._. baumannii_NN grown_VBN in_IN absence_NN of_IN
        iron_NN ._. Also_RB being_VBG IgM_NNP subtype_NN ,_, these_DT were_VBD efficient_JJ in_IN
        complement_VB mediated_JJ lysis_NNS of_IN bacteria_NNS ._. They_PRP also_RB enhanced_VBD
        the_DT phagocytosis_NNS of_IN 
        A_DT ._. baumannii_NN 6_CD -_: 8_CD folds_NNS more_JJR as_IN
        compared_VBN to_TO preimmune_NN sera_NN of_IN mice_NNS in_IN invitro_NN experiments_NNS ._.
        These_DT results_NNS showed_VBD that_IN the_DT IROMPs_NNP are_VBP surfaced_VBN exposed_VBN
        immunodominant_NN antigens_NNS ,_, which_WDT play_VBP significant_JJ role_NN in_IN
        virulence_NN ._. Earlier_RBR also_RB the_DT antibodies_NNS against_IN 70_CD kDa_NN
        IROMPs_NNP of_IN 
        Neisseria_NNP meningitidis_NNS have_VBP been_VBN
        shown_VBN to_TO be_VB bactericidal_NN [_NN 9_CD ]_NN ._. These_DT antibodies_NNS may_MD have_VB
        a_DT role_NN as_IN protective_JJ antibodies_NNS in_IN the_DT course_NN of_IN infection_NN
        inside_IN a_DT human_JJ host_NN ._. The_DT antisera_NN against_IN Tbp_NNP 1_CD and_CC Tbp_NNP 2_CD
        killed_VBD the_DT homologous_RB as_RB well_RB as_IN majority_NN of_IN heterologous_JJ
        strains_NNS examined_VBD ,_, with_IN varying_VBG efficiency_NN [_NN 30_CD ]_NN ._. Sokol_NNP
        and_CC Woods_NNP [_NN 31_CD ]_NN have_VBP pointed_VBN out_RP that_IN the_DT antibodies_NNS
        against_IN pyoverdin_NN and_CC pyochelin_NN receptor_NN proteins_NNS in_IN 
        Pseudomonas_NNP aeruginosa_NN ,_, enhances_VBZ the_DT
        opsonization_NN process_NN by_IN polymorphonucleocytes_NNS ._. They_PRP have_VBP
        also_RB shown_VBN that_IN these_DT antibodies_NNS were_VBD protective_JJ in_IN a_DT burn_VB
        mouse_NN model_NN system_NN ._.
        We_PRP observed_VBD that_IN these_DT antibodies_NNS significantly_RB reduced_VBD
        the_DT uptake_NN of_IN iron_NN by_IN 
        A_DT ._. baumannii_NN cells_NNS ._. Meyer_NNP 
        et_CC ._. al_NN ._. [_NN 11_CD ]_NN and_CC Pintor_NNP 
        et_CC ._. al_NN ._. [_NN 13_CD 14_CD ]_NN have_VBP shown_VBN the_DT
        specific_JJ block_NN of_IN iron_NN uptake_NN via_IN siderophore_NN and_CC
        transferrin_NN using_VBG polyclonal_NN and_CC monoclonal_NN antibodies_NNS
        against_IN IROMPs_NNP of_IN 
        Pseudomona_NNP sp_NN ._. and_CC 
        Neisseria_NNP sp_NN ._. respectively_RB ._. We_PRP also_RB
        observed_VBD that_IN the_DT antibodies_NNS raised_VBD against_IN the_DT IROMPs_NNP of_IN 
        A_DT ._. baumannii_NN also_RB inhibited_VBD the_DT
        binding_JJ of_IN iron_NN siderophore_NN complex_JJ to_TO purified_JJ OMPs_NNP ._. The_DT
        blocking_VBG in_IN the_DT uptake_NN of_IN iron_NN resulted_VBD ultimately_RB in_IN the_DT
        growth_NN inhibition_NN of_IN the_DT bacterium_NN ._.
        This_DT mechanism_NN of_IN iron_NN uptake_NN may_MD constitute_VB an_DT
        important_JJ virulence_NN factor_NN ,_, which_WDT can_MD help_VB in_IN establishing_VBG
        infection_NN in_IN the_DT host_NN [_NN 26_CD ]_NN ._. The_DT study_NN of_IN this_DT virulence_NN
        system_NN may_MD help_VB in_IN the_DT better_JJR understanding_NN of_IN the_DT
        bacterial_JJ pathogenesis_NNS especially_RB in_IN an_DT opportunistic_JJ
        pathogen_NN like_IN 
        Acinetobacter_NNP sp_NN ._. 
      
      
        Materials_NNS and_CC Methods_NNP
        
          Bacterial_NNP strains_NNS and_CC growth_NN conditions_NNS
          The_DT 
          Acinetobacter_NNP baumannii_NN ATCC_NNP 19606_CD
          strain_NN was_VBD procured_JJ from_IN American_NNP Type_NNP Cell_NNP Culture_NNP ,_, USA_NNP ._.
          It_PRP was_VBD grown_VBN in_IN Iron_NNP depleted_VBD chemically_RB defined_VBN media_NNS
          (_( CDM-Fe_NNP )_) and_CC in_IN iron_NN rich_JJ (_( CDM_NNP +_NN Fe_NNP )_) media_NNS ._. Outer_NNP membrane_NN
          proteins_NNS were_VBD prepared_VBN as_IN described_VBN by_IN Goel_NNP et_CC ._. al_NN ._. [_NN 32_CD ]_NN
          ,_, and_CC the_DT protein_NN concentration_NN was_VBD measured_VBN by_IN Bradford_NNP
          assay_NN [_NN 33_CD ]_NN ._. The_DT OMPs_NNP were_VBD resolved_VBN on_IN SDSPAGE_NNP
          according_VBG to_TO Lugtenberg_NNP 's_POS protocol_NN [_NN 34_CD ]_NN ._.
        
        
          Production_NN of_IN monoclonal_NN antibodies_NNS
          For_IN immunization_NN of_IN Balb_NNP /_NN c_SYM mice_NNS ,_, the_DT area_NN of_IN the_DT
          SDS-PAGE_NNP gel_NN corresponding_JJ to_TO the_DT bands_NNS representing_VBG the_DT
          IROMPs_NNP were_VBD cut_VBN and_CC used_VBN as_IN an_DT antigen_NN [_NN 35_CD ]_NN ._. First_CD
          dose_NN was_VBD given_VBN Intraperitonealy_NNP mixed_VBN with_IN 250_CD μl_NN of_IN
          complete_JJ Freund_NNP 's_POS adjuvant_NN followed_VBD by_IN three_CD doses_NNS in_IN
          Freund_NNP 's_POS Incomplete_NNP Adjuvant_NNP at_IN an_DT interval_NN of_IN one_CD week_NN ._.
          Final_JJ booster_NN was_VBD given_VBN in_IN normal_JJ saline_NN ,_,
          intraperitonealy_RB ,_, just_RB four_CD days_NNS before_IN fusion_NN ._. The_DT
          spleen_NN cells_NNS were_VBD fused_JJ with_IN mouse_NN myeloma_NN cell_NN line_NN Sp_NNP 2_CD O_NNP
          14_CD /_NN Ag_NNP as_IN described_VBN previously_RB by_IN using_VBG PEG_NNP (_( polyethylene_NN
          glycol_NN 1450_CD )_) [_NN 36_CD 37_CD ]_NN ._. Screening_NNP of_IN hybridomas_NNS was_VBD done_VBN
          by_IN testing_VBG culture_NN supernatants_NNS in_IN ELISA_NNP using_VBG two_CD
          different_JJ antigens_NNS ._.
          (_( A_DT )_) OMPs_NNP expressed_VBN by_IN bacteria_NNS grown_VBN in_IN CDM-Fe_NNP medium_NN
          i_NNP ._. e_SYM ._. antigen_NN A_DT
          (_( B_NNP )_) OMPs_NNP expressed_VBN by_IN bacteria_NNS grown_VBN in_IN CDM_NNP +_NN Fe_NNP medium_NN
          i_NNP ._. e_SYM ._. antigen_NN B_NNP
          Hybridoma_NNP supernatants_NNS reacting_VBG with_IN antigen_NN A_DT alone_RB
          without_IN any_DT signal_NN with_IN antigen_NN B_NNP were_VBD selected_VBN and_CC
          subcloned_JJ thrice_NN by_IN limiting_VBG dilution_NN ._. Clones_NNP of_IN interest_NN
          were_VBD expanded_VBN and_CC cultured_JJ in_IN the_DT peritoneal_JJ cavities_NNS of_IN
          pristane_NN primed_VBN Balb_NNP /_NN c_SYM mice_NNS to_TO obtain_VB ascitic_JJ fluid_NN ._.
        
        
          ELISA_NNP
          Antigen_NNP A_DT and_CC B_NNP were_VBD diluted_VBN to_TO final_JJ concentration_NN of_IN
          2_CD ._. 5_CD μg_NN /_NN ml_NN in_IN PBS_NNP (_( pH_NN 7_CD ._. 2_LS )_) ._. 100_CD μl_NN of_IN this_DT antigen_NN was_VBD
          added_VBN to_TO 96_CD well_RB ELISA_NNP plate_NN (_( High_NNP binding_JJ ELISA_NNP plates_NNS ,_,
          Costar_NNP ,_, USA_NNP )_) and_CC were_VBD allowed_VBN to_TO adsorb_NN for_IN 16_CD -_: 18_CD hrs_NNS at_IN
          4_CD °_NN C_NNP ._. The_DT plates_NNS were_VBD washed_VBN thrice_NN with_IN PBS_NNP containing_VBG
          0_CD ._. 05_CD %_NN Tween_NNP 20_CD (_( Sigma_NNP Co_NNP ._. USA_NNP )_) ._. The_DT nonspecific_JJ binding_JJ
          sites_NNS on_IN the_DT plate_NN were_VBD blocked_VBN by_IN 2_CD %_NN nonfat_JJ milk_NN powder_NN
          at_IN 37_CD °_NN C_NNP for_IN 3_CD hrs_NNS ._. 100_CD μl_NN of_IN the_DT antibody_NN was_VBD added_VBN to_TO
          the_DT wells_NNS and_CC the_DT plates_NNS were_VBD further_JJ incubated_JJ for_IN 3_CD hrs_NNS
          at_IN 37_CD °_NN C_NNP ._. The_DT rabbit_NN antimouse_NN (_( Dakopats_NNP Switzerland_NNP )_)
          peroxidase_NN conjugated_JJ immunoglobulin_NN was_VBD used_VBN at_IN working_VBG
          dilution_NN of_IN 1_CD :_: 3000_CD ._. O-P_NNP henyalenediamine_NN (_( OPD_NNP ,_, Sigma_NNP Inc_NNP ._.
          USA_NNP )_) and_CC H_NNP 
          2_CD O_NNP 
          2_CD was_VBD used_VBN as_IN chromogen_NN and_CC substrate_NN ,_,
          respectively_RB ._. The_DT optical_JJ density_NN were_VBD taken_VBN by_IN ELISA_NNP
          reader_NN at_IN 492_CD nm_NN ._. Cross_NNP reactivity_NN of_IN the_DT monoclonal_NN
          antibodies_NNS was_VBD checked_VBN against_IN 
          E_NNP ._. coli_NNS and_CC 
          Pseudomonas_NNP aeruginosa_NN IROMPs_NNP in_IN
          ELISA_NNP as_IN described_VBN above_IN ._.
        
        
          Determination_NNP of_IN immunoglobulin_NN isotype_NN
          The_DT isotyping_VBG of_IN monoclonal_NN antibodies_NNS was_VBD done_VBN using_VBG
          commercially_RB available_JJ isotyping_VBG kit_NN based_VBN on_IN ELISA_NNP
          (_( Sigma_NNP Inc_NNP ._. ,_, USA_NNP )_) as_IN described_VBN by_IN manufacturer_NN ._.
        
        
          Immunoblotting_NNP
          OMPs_NNP from_IN SDS-PAGE_NNP were_VBD transferred_VBN
          electrophoretically_RB to_TO Nitrocellulose_NNP paper_NN (_( 0_CD ._. 45_CD μm_NN
          Bio-_NNP Rad_NNP ,_, USA_NNP )_) using_VBG semidry_NN blotter_NN (_( Bio-_NNP Rad_NNP ,_, USA_NNP )_) as_IN
          described_VBN by_IN manufacturer_NN by_IN a_DT modification_NN of_IN Towbin_NNP 's_POS [_NN
          38_CD ]_NN procedure_NN ._. The_DT NC_NNP paper_NN was_VBD washed_VBN twice_RB with_IN PBS_NNP pH_NN
          7_CD ._. 2_CD ._. One_CD part_NN of_IN the_DT NC_NNP paper_NN was_VBD stained_JJ with_IN Ponceau_NNP S_NNP
          (_( Merck_NNP ._. Germany_NNP )_) for_IN staining_VBG the_DT proteins_NNS to_TO check_VB the_DT
          transfer_NN efficiency_NN and_CC for_IN marking_VBG the_DT position_NN of_IN
          molecular_JJ weights_NNS ._. The_DT other_JJ part_NN of_IN NC_NNP paper_NN was_VBD used_VBN
          for_IN immunoblotting_VBG ._. Nonspecific_NNP binding_JJ sites_NNS were_VBD
          blocked_VBN by_IN incubating_VBG the_DT NC_NNP paper_NN in_IN 2_CD %_NN bovine_JJ serum_NN
          albumin_NN and_CC 3_CD %_NN nonfat_JJ milk_NN powder_NN at_IN 37_CD °_NN C_NNP for_IN 3_CD hours_NNS ._. NC_NNP
          paper_NN was_VBD washed_VBN thrice_NN with_IN PBS_NNP containing_VBG 0_CD ._. 05_CD %_NN Tween_NNP
          20_CD ._. The_DT NC_NNP paper_NN was_VBD incubated_JJ at_IN 4_CD °_NN C_NNP for_IN overnight_JJ with_IN
          either_DT monoclonal_NN or_CC polyclonal_NN antibodies_NNS ._. The_DT rabbit_NN
          antimouse_NN peroxidase_NN conjugated_JJ immunoglobulin_NN (_( Dakopats_NNP ,_,
          Switzerland_NNP )_) was_VBD used_VBN at_IN a_DT dilution_NN of_IN 1_CD :_: 1000_CD and_CC
          incubated_JJ at_IN 37_CD °_NN C_NNP for_IN 3_CD h_NN ._. The_DT blots_NNS were_VBD developed_VBN using_VBG
          DAB_NNP (_( diaminobenzimidine_NN )_) and_CC H_NNP 
          2_CD O_NNP 
          2_CD as_IN chromogen_NN and_CC substrate_NN ,_,
          respectively_RB ._.
        
        
          Bactericidal_NNP assay_NN
          Bactericidal_NNP assay_NN of_IN monoclonal_NN antibodies_NNS was_VBD
          carried_VBN out_IN as_IN described_VBN by_IN Poolman_NNP et_CC ._. al_NN ._. [_NN 19_CD ]_NN ._.
          Briefly_NNP ,_, 10_CD 7_CD cells_NNS of_IN 
          A_DT ._. baumannii_NN ATCC_NNP 19606_CD (_( grown_VBN in_IN
          iron_NN deficient_NN medium_NN )_) in_IN 100_CD μl_NN volume_NN were_VBD taken_VBN in_IN an_DT
          eppendrof_NN ,_, 100_CD μl_NN of_IN monoclonal_NN antibodies_NNS culture_NN
          supernatant_NN (_( undiluted_JJ )_) was_VBD added_VBN to_TO it_PRP and_CC incubated_JJ at_IN
          37_CD °_NN C_NNP for_IN 1_CD hour_NN ._. The_DT human_JJ complement_VB from_IN immunoglobulin_NN
          deficient_NN patient_NN was_VBD added_VBN (_( Courtesy_NNP of_IN Medical_NNP Oncology_NNP
          Unit_NNP ,_, AIIMS_NNP New_NNP Delhi_NNP India_NNP )_) to_TO a_DT final_JJ concentration_NN of_IN
          10_CD %_NN with_IN 10_CD mM_NN MgCl_NNP 
          2_CD and_CC CaCl_NNP 
          2_CD ,_, incubated_JJ further_RB for_IN 1_CD hour_NN at_IN
          37_CD °_NN C_NNP ._. The_DT reaction_NN mixture_NN were_VBD appropriately_RB diluted_VBN ,_,
          plated_JJ on_IN to_TO nutrient_NN agar_NN plate_NN and_CC incubated_JJ at_IN 37_CD °_NN C_NNP
          for_IN overnight_JJ ._. Bacterial_NNP colonies_NNS were_VBD counted_VBN the_DT next_JJ
          day_NN to_TO look_VB for_IN percentage_NN reduction_NN ._. The_DT percentage_NN
          reduction_NN was_VBD calculated_VBN as_IN follows_VBZ
          Control-_NNP Test_NNP X_NNP 100_CD /_NN Control_NNP
        
        
          Opsonophagocytic_NNP assay_NN
          The_DT assay_NN described_VBN by_IN Speert_NNP et_CC al_NN ._. [_NN 39_CD ]_NN was_VBD used_VBN
          to_TO measure_VB opsonophagocytic_JJ activity_NN of_IN monoclonal_NN
          antibodies_NNS ._. The_DT polymorphonuclear_NN leucocytes_NNS (_( PMN_NNP )_) were_VBD
          isolated_VBN from_IN pooled_VBN normal_JJ healthy_JJ human_JJ blood_NN by_IN Ficoll_NNP
          Hypaque_NNP density_NN gradient_NN centrifugation_NN ._. 
          A_DT ._. baumannii_NN ATCC_NNP 19606_CD (_( 10_CD
          7_CD bacterial_JJ cells_NNS /_NN 100_CD μl_NN )_) grown_VBN in_IN CDM-Fe_NNP medium_NN were_VBD
          incubated_JJ with_IN 100_CD μl_NN of_IN monoclonal_NN antibody_NN culture_NN
          supernatant_NN for_IN 30_CD min_NN at_IN 37_CD °_NN C_NNP ._. To_TO this_DT 10_CD 6_CD PMN_NNP in_IN 100_CD μl_NN
          volume_NN was_VBD added_VBN and_CC kept_VBD in_IN orbital_NN shaker_NN (_( 100_CD rpm_NN )_) at_IN
          37_CD °_NN C_NNP for_IN 90_CD min_NN ._. A_DT duplicate_VB set_NN of_IN assay_NN was_VBD incubated_JJ
          at_IN 4_CD °_NN C_NNP to_TO measure_VB the_DT nonspecific_JJ attachment_NN of_IN bacteria_NNS ._.
          After_IN incubation_NN the_DT tubes_NNS were_VBD centrifuged_JJ at_IN 300_CD g_SYM and_CC
          cell_NN pellet_NN was_VBD washed_VBN gently_RB in_IN Hank_NNP 's_POS balanced_JJ salt_NN
          solution_NN (_( HBSS_NNP )_) at_IN least_JJS thrice_NN ._. The_DT pellet_NN was_VBD
          resuspended_JJ in_IN 0_CD ._. 1_CD ml_NN of_IN HBSS_NNP and_CC one_CD drop_NN of_IN it_PRP was_VBD
          placed_VBN on_IN glass_NN slide_NN ,_, air-dried_JJ heat_NN fixed_VBN and_CC stained_JJ
          with_IN Gram_NNP Stain_NNP ._. The_DT slide_NN was_VBD seen_VBN under_IN oil_NN immersion_NN
          field_NN of_IN light_JJ microscope_NN ._. The_DT number_NN of_IN bacteria_NNS within_IN
          the_DT ,_, cytoplasm_NN of_IN 50_CD PMNs_NNP were_VBD counted_VBN ._. The_DT mean_JJ number_NN
          of_IN bacteria_NNS per_IN PMN_NNP obtained_VBD from_IN 4_CD °_NN C_NNP assay_NN was_VBD
          subtracted_VBN from_IN the_DT number_NN obtained_VBN from_IN 37_CD °_NN C_NNP assay_NN to_TO
          get_VB the_DT final_JJ results_NNS ._. Same_JJ set_NN of_IN experiments_NNS was_VBD
          repeated_VBN with_IN bacteria_NNS grown_VBN in_IN CDM_NNP +_NN Fe_NNP medium_NN ._.
        
        
          Electron_NNP microscopy_NN
          For_IN electron_NN microscopy_NN modified_VBN procedure_NN of_IN Root_NN et_CC ._.
          al_NN ._. [_NN 40_CD ]_NN was_VBD followed_VBN ._. Mixture_NNP of_IN 10_CD 7_CD bacteria_NNS and_CC 10_CD
          6_CD PMNs_NNP were_VBD combined_VBN and_CC processed_VBN for_IN opsonization_NN as_IN
          mentioned_VBN above_IN except_IN the_DT last_JJ wash_NN ,_, which_WDT was_VBD in_IN 0_CD ._. 1_CD M_NNP
          sodium_NN cacodylate_NN buffer_NN pH_NN 7_CD ._. 2_CD ._. To_TO the_DT pellet_NN 1_CD ml_NN of_IN
          2_CD ._. 5_CD %_NN glutraldehyde_NN (_( made_VBN in_IN 0_CD ._. 1_CD M_NNP sodium_NN cacodylate_NN
          buffer_NN )_) was_VBD added_VBN and_CC centrifuged_JJ at_IN 1150_CD g_SYM for_IN 10_CD min_NN ,_,
          supernatant_NN was_VBD decanted_JJ ._. The_DT cell_NN pellet_NN was_VBD fixed_VBN by_IN
          adding_VBG 2_CD ._. 5_CD %_NN glutraldehyde_NN for_IN 4_CD h_NN and_CC the_DT pellet_NN was_VBD
          washed_VBN in_IN sodium_NN cacodylate_NN buffer_NN ._. The_DT pellet_NN was_VBD post_NN
          fixed_VBN in_IN 1_CD %_NN osmium_NN tetraoxide_NN ,_, embedded_VBN in_IN 1_CD %_NN agar_NN ._. The_DT
          embedded_VBN sample_NN was_VBD dehydrated_JJ in_IN graded_JJ series_NN of_IN
          alcohol_NN and_CC finally_RB embedded_VBN in_IN Araldite_NNP resin_NN ._. It_PRP was_VBD
          sectioned_JJ ,_, poststained_JJ with_IN uranyl_NN acetate_NN and_CC lead_VB and_CC
          samples_NNS were_VBD viewed_VBN with_IN a_DT Philips_NNP 400_CD electronmicroscope_NN
          to_TO look_VB for_IN phagocytosed_JJ bacteria_NNS ._.
        
        
          Blocking_NNP of_IN iron_NN uptake_NN by_IN bacteria_NNS
          For_IN studying_VBG the_DT role_NN of_IN monoclonal_NN antibodies_NNS in_IN
          blocking_VBG of_IN iron_NN uptake_NN pathway_NN ,_, we_PRP purified_JJ the_DT
          siderophore_NN by_IN a_DT modified_VBN method_NN of_IN Smith_NNP [_NN 17_CD ]_NN ._.
          Briefly_NNP the_DT culture_NN supernatant_NN of_IN bacteria_NNS grown_VBN in_IN
          CDM-Fe_NNP medium_NN was_VBD extracted_VBN twice_RB with_IN ethyl_NN acetate_NN ._. The_DT
          ethyl_NN acetate_NN was_VBD reduced_VBN to_TO 0_CD ._. 5_CD ml_NN by_IN rotary_JJ evaporation_NN
          (_( Buchi_NNP rotary_JJ evaporator_NN )_) at_IN 30_CD °_NN C_NNP under_IN reduced_VBN pressure_NN ._.
          This_DT sample_NN was_VBD loaded_VBN on_IN Whatman_NNP 3_CD mm_NN chromatography_NN
          paper_NN and_CC developed_VBN using_VBG solvent_JJ system_NN of_IN water_NN :_: Acetic_NNP
          Acid_NNP :_: Acetone_NNP in_IN ratio_NN of_IN 90_CD :_: 10_CD :_: 1_CD ._. One_CD portion_NN of_IN the_DT
          chromatogram_NN was_VBD stained_JJ with_IN 0_CD ._. 1_CD M_NNP FeCl_NNP 
          3_CD in_IN 0_CD ._. 1_CD M_NNP HCl_NNP ._. The_DT corresponding_JJ band_NN
          was_VBD excised_VBN and_CC siderophore_NN was_VBD eluted_JJ in_IN ethyl_NN acetate_NN
          for_IN 48_CD hrs_NNS at_IN room_NN temperature_NN ._. After_IN evaporation_NN of_IN
          ethyl_NN acetate_NN ,_, purified_JJ siderophore_NN was_VBD re-suspended_JJ in_IN
          distilled_VBN water_NN and_CC stored_VBD at_IN -_: 80_CD °_NN C_NNP ._. The_DT type_NN of_IN
          siderophore_NN was_VBD determined_VBN by_IN Arnow_NNP 's_POS [_NN 41_CD ]_NN and_CC Csaky_NNP 's_POS
          method_NN [_NN 42_CD ]_NN ._. The_DT concentration_NN of_IN siderophore_NN was_VBD
          determined_VBN using_VBG 2_CD -_: 3_CD dihydroxybenzoic_JJ acid_NN as_IN a_DT standard_NN
          by_IN Universal_NNP Chemical_NNP assay_NN as_IN described_VBN by_IN Schwyn_NNP 's_POS [_NN 43_CD
          ]_NN ._. 2_CD mM_NN of_IN 50_CD μl_NN purified_JJ siderophore_NN was_VBD incubated_JJ with_IN
          either_DT 10_CD μM_NN 55_CD FeCl_NNP 
          3_CD (_( specific_JJ activity_NN 2_CD ._. 068_CD Mci_NNP /_NN g_SYM of_IN
          iron_NN ,_, Bhabha_NNP Atomic_NNP Research_NNP Center_NNP Trombay_NNP ,_, India_NNP )_) or_CC
          59_CD FeCl_NNP 
          3_CD (_( specific_JJ activity_NN 250_CD ._. 49_CD GBq_NNP /_NN g_SYM of_IN
          iron_NN ,_, Bhabha_NNP Atomic_NNP Research_NNP Center_NNP Trombay_NNP ,_, India_NNP )_) ._. The_DT
          mixture_NN was_VBD incubated_JJ at_IN room_NN temperature_NN for_IN 30_CD minutes_NNS ._.
          At_IN the_DT end_NN the_DT unbound_NN radiolabelled_JJ iron_NN was_VBD removed_VBN by_IN
          chromatography_NN using_VBG sephadex_NN G-_NNP 10_CD as_IN described_VBN by_IN
          Rosenberg_NNP [_NN 44_CD ]_NN ._. The_DT uptake_NN of_IN radiolabelled_JJ iron_NN
          siderophore_NN was_VBD studied_VBN by_IN the_DT method_NN described_VBN by_IN
          Rosenberg_NNP [_NN 44_CD ]_NN ._. Briefly_NNP 
          A_DT ._. baumannii_NN was_VBD grown_VBN in_IN CDM-Fe_NNP
          medium_NN also_RB in_IN CDM_NNP +_NN Fe_NNP medium_NN to_TO a_DT mid_JJ exponential_NN phase_NN
          and_CC was_VBD washed_VBN twice_RB with_IN uptake_NN medium_NN (_( 30_CD mM_NN Na_NNP 
          2_CD HPO_NNP 
          4_CD ,_, 10_CD mM_NN K_NNP 
          2_CD HPO_NNP 
          4_CD ,_, 10_CD mM_NN (_( NH_NNP 
          4_LS )_) 
          2_CD SO_NNP 
          4_CD ,_, 1_CD mM_NN MgCl_NNP 
          2_CD and_CC 40_CD μM_NN CaCl_NNP 
          2_CD pH_NN 6_CD ._. 9_CD )_) at_IN 4_CD °_NN C_NNP and_CC re-suspended_JJ in_IN
          the_DT same_JJ medium_NN at_IN a_DT density_NN of_IN A_DT 
          470_CD =_SYM 0_CD ._. 4_CD ._. The_DT washed_VBN cells_NNS were_VBD
          incubated_JJ at_IN 37_CD °_NN C_NNP for_IN 15_CD minutes_NNS ._. The_DT uptake_NN was_VBD
          initiated_VBN by_IN adding_VBG equal_JJ volume_NN of_IN radiolabelled_JJ 55_CD Fe_NNP
          siderophore_NN to_TO the_DT bacterial_JJ suspension_NN and_CC shaken_VBN at_IN 300_CD
          rpm_NN ._. Aliquots_NNP of_IN 500_CD μl_NN were_VBD withdrawn_VBN after_IN every_DT 5_CD
          minutes_NNS interval_NN and_CC filtered_VBN immediately_RB on_IN glass_NN
          microfiber_NN filter_NN and_CC washed_VBN with_IN 2_CD ml_NN of_IN uptake_NN medium_NN ._.
          The_DT membranes_NNS were_VBD dried_VBN at_IN 37_CD °_NN C_NNP and_CC measured_VBN as_IN counts_VBZ
          per_IN minutes_NNS on_IN β-scintillation_JJ counter_NN (_( Pharmacia_NNP )_) on_IN the_DT
          3_CD H_NNP channel_NN ._. In_IN parallel_JJ ,_, bacterial_JJ cells_NNS were_VBD also_RB
          incubated_JJ with_IN radiolabelled_JJ iron_NN alone_RB and_CC unlabelled_JJ
          siderophore_NN as_IN a_DT control_NN ._.
          To_TO look_VB for_IN the_DT role_NN of_IN monoclonal_NN antibodies_NNS against_IN
          IROMPs_NNP in_IN blocking_VBG the_DT iron_NN uptake_NN the_DT bacterial_JJ cells_NNS
          were_VBD pre-incubated_JJ with_IN 100_CD μl_NN of_IN undiluted_JJ monoclonal_NN
          antibody_NN culture_NN supernatant_NN for_IN 1_CD h_NN at_IN 37_CD °_NN C_NNP before_IN
          addition_NN of_IN radiolabelled_JJ iron_NN siderophore_NN complex_JJ ._. After_IN
          incubation_NN with_IN antibodies_NNS the_DT bacterial_JJ cells_NNS were_VBD
          washed_VBN twice_RB with_IN uptake_NN buffer_NN to_TO remove_VB unbound_NN
          antibodies_NNS ._. Similarly_RB as_IN like_IN in_IN uptake_NN ,_, radioactivity_NN
          retained_VBD on_IN the_DT filter_NN was_VBD counted_VBN on_IN β-scintillation_JJ
          counter_NN on_IN 3_CD H_NNP channel_NN ._.
        
        
          Binding_NNP of_IN radiolabelled_JJ iron_NN siderophore_NN complex_JJ
          to_TO OMPs_NNP
          Binding_NNP of_IN radiolabelled_JJ 55_CD Fe_NNP siderophore_NN complex_JJ to_TO
          OMPs_NNP was_VBD carried_VBN out_IN as_IN described_VBN by_IN Meyer_NNP et_CC al_NN ._. [_NN 11_CD ]_NN
          ._. 100_CD μg_NN of_IN OMPs_NNP in_IN 0_CD ._. 125_CD M_NNP Tris_NNP HCl_NNP pH_NN 6_CD ._. 8_CD was_VBD mixed_VBN
          with_IN 0_CD ._. 1_CD ml_NN of_IN siderophore_NN labeled_VBN with_IN 55_CD Fe_NNP (_( as_IN
          described_VBN above_IN )_) ._. The_DT total_JJ volume_NN of_IN the_DT mixture_NN was_VBD
          adjusted_VBN to_TO 1_CD ml_NN with_IN uptake_NN medium_NN and_CC the_DT reaction_NN
          mixture_NN were_VBD incubated_JJ for_IN 10_CD minutes_NNS at_IN 37_CD °_NN C_NNP ._. This_DT was_VBD
          filtered_VBN through_IN 0_CD ._. 22_CD μm_NN filter_NN and_CC washed_VBN twice_RB with_IN 2_CD
          ml_NN of_IN uptake_NN medium_NN ._. The_DT radiolabeled_JJ iron_NN retained_VBD on_IN
          the_DT filter_NN was_VBD counted_VBN as_IN counts_VBZ per_IN minutes_NNS on_IN
          β-scintillation_JJ counter_NN on_IN 3_CD H_NNP channel_NN ._. To_TO determine_VB the_DT
          nature_NN of_IN the_DT binding_JJ receptor_NN ,_, the_DT OMP_NNP preparation_NN was_VBD
          subjected_VBN to_TO digestion_NN with_IN proteinase_NN K_NNP (_( 10_CD mg_NN /_NN ml_NN )_) for_IN 1_CD
          hr_NN at_IN 37_CD °_NN C_NNP prior_RB to_TO the_DT incubation_NN with_IN iron_NN siderophore_NN
          complex_JJ ._.
          To_TO test_VB the_DT blocking_VBG of_IN iron_NN siderophore_NN to_TO OMP_NNP 
          s_VBZ ,_, it_PRP was_VBD preincubated_JJ with_IN
          monoclonal_NN antibodies_NNS for_IN 1_CD h_NN at_IN 37_CD °_NN C_NNP as_IN described_VBN in_IN
          uptake_NN experiment_NN and_CC then_RB binding_JJ assay_NN was_VBD
          performed_VBN
        
      
    
  
